AEON Biopharma, Inc.

8-K Regulation FD disclosure; Other events Aug 3, 2026 8-K Other events Jul 23, 2026 8-K Entered a material agreement; Other events Jul 15, 2026 8-K Shareholder vote results Jun 17, 2026 8-K Regulation FD disclosure May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Delisting notice or listing-rule failure Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Director or officer change Mar 9, 2026 8-K Unregistered sale of equity; Director or officer change; Shareholder vote results; Regulation FD disclosure; Other events Jan 21, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 15, 2025 8-K Regulation FD disclosure Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Entered a material agreement; Unregistered sale of equity Nov 13, 2025 8-K Regulation FD disclosure Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q/A Quarter ended 2025-03-31 Jun 11, 2025 10-K/A Fiscal year ended 2024-12-31 Jun 11, 2025 8-K Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Delisting notice or listing-rule failure Apr 25, 2025 8-K Director or officer change Apr 21, 2025 8-K Director or officer change Apr 8, 2025 8-K Director or officer change; Regulation FD disclosure Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release) Mar 24, 2025 8-K Regulation FD disclosure Mar 10, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Feb 24, 2025 8-K Delisting notice or listing-rule failure Feb 7, 2025 8-K Entered a material agreement; Other events Jan 7, 2025 8-K Regulation FD disclosure Jan 6, 2025 8-K Amended charter or bylaws Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024